Overview

OpenBiome is a nonprofit organization dedicated to expanding access to fecal microbiota transplantation (FMT) and to advancing research in the microbiome field. It provides screened and processed FMT preparations for use in clinical settings to treat Clostridioides difficile infections, which are often resistant to standard antibiotic treatments.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to OpenBiome in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.